nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ORM1—Vandetanib—thyroid cancer	0.39	0.528	CbGbCtD
Telaprevir—ALB—Vandetanib—thyroid cancer	0.164	0.222	CbGbCtD
Telaprevir—ABCB1—Sorafenib—thyroid cancer	0.0518	0.0701	CbGbCtD
Telaprevir—CYP3A4—Vandetanib—thyroid cancer	0.0515	0.0696	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—thyroid cancer	0.0314	0.0425	CbGbCtD
Telaprevir—CYP3A4—Sorafenib—thyroid cancer	0.031	0.042	CbGbCtD
Telaprevir—CYP3A4—Doxorubicin—thyroid cancer	0.0188	0.0255	CbGbCtD
Telaprevir—CELA1—head—thyroid cancer	0.0116	0.157	CbGeAlD
Telaprevir—CTSS—neck—thyroid cancer	0.00809	0.11	CbGeAlD
Telaprevir—CTSK—saliva-secreting gland—thyroid cancer	0.0072	0.0976	CbGeAlD
Telaprevir—Hypothyroidism—Vandetanib—thyroid cancer	0.00699	0.0373	CcSEcCtD
Telaprevir—CTSS—saliva-secreting gland—thyroid cancer	0.00631	0.0855	CbGeAlD
Telaprevir—Lymphopenia—Sorafenib—thyroid cancer	0.00592	0.0316	CcSEcCtD
Telaprevir—CTSK—trachea—thyroid cancer	0.00555	0.0753	CbGeAlD
Telaprevir—Endocrine disorder—Vandetanib—thyroid cancer	0.00542	0.0289	CcSEcCtD
Telaprevir—CTSS—trachea—thyroid cancer	0.00487	0.066	CbGeAlD
Telaprevir—Hypothyroidism—Sorafenib—thyroid cancer	0.00472	0.0252	CcSEcCtD
Telaprevir—Proctitis—Epirubicin—thyroid cancer	0.00458	0.0245	CcSEcCtD
Telaprevir—CTSK—thyroid gland—thyroid cancer	0.00439	0.0595	CbGeAlD
Telaprevir—Proctitis—Doxorubicin—thyroid cancer	0.00424	0.0226	CcSEcCtD
Telaprevir—CMA1—lymph node—thyroid cancer	0.00424	0.0574	CbGeAlD
Telaprevir—CTSK—head—thyroid cancer	0.0039	0.0528	CbGeAlD
Telaprevir—CTSS—thyroid gland—thyroid cancer	0.00385	0.0522	CbGeAlD
Telaprevir—Endocrine disorder—Sorafenib—thyroid cancer	0.00365	0.0195	CcSEcCtD
Telaprevir—CTSS—head—thyroid cancer	0.00342	0.0463	CbGeAlD
Telaprevir—Blood creatinine increased—Vandetanib—thyroid cancer	0.00305	0.0163	CcSEcCtD
Telaprevir—Hypokalaemia—Vandetanib—thyroid cancer	0.00297	0.0158	CcSEcCtD
Telaprevir—CTSK—lymph node—thyroid cancer	0.00273	0.037	CbGeAlD
Telaprevir—Infestation—Vandetanib—thyroid cancer	0.00251	0.0134	CcSEcCtD
Telaprevir—Infestation NOS—Vandetanib—thyroid cancer	0.00251	0.0134	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00249	0.0133	CcSEcCtD
Telaprevir—Eczema—Sorafenib—thyroid cancer	0.00245	0.0131	CcSEcCtD
Telaprevir—CTSS—lymph node—thyroid cancer	0.00239	0.0324	CbGeAlD
Telaprevir—Proctalgia—Epirubicin—thyroid cancer	0.00239	0.0127	CcSEcCtD
Telaprevir—Renal failure acute—Sorafenib—thyroid cancer	0.00238	0.0127	CcSEcCtD
Telaprevir—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00238	0.0127	CcSEcCtD
Telaprevir—Urinary tract disorder—Vandetanib—thyroid cancer	0.00223	0.0119	CcSEcCtD
Telaprevir—Urethral disorder—Vandetanib—thyroid cancer	0.00221	0.0118	CcSEcCtD
Telaprevir—Proctalgia—Doxorubicin—thyroid cancer	0.00221	0.0118	CcSEcCtD
Telaprevir—Lymphopenia—Epirubicin—thyroid cancer	0.00219	0.0117	CcSEcCtD
Telaprevir—Erythema multiforme—Vandetanib—thyroid cancer	0.00213	0.0114	CcSEcCtD
Telaprevir—Eye disorder—Vandetanib—thyroid cancer	0.00211	0.0112	CcSEcCtD
Telaprevir—Anorectal discomfort—Epirubicin—thyroid cancer	0.00205	0.0109	CcSEcCtD
Telaprevir—Lymphopenia—Doxorubicin—thyroid cancer	0.00202	0.0108	CcSEcCtD
Telaprevir—Hypokalaemia—Sorafenib—thyroid cancer	0.002	0.0107	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00198	0.0106	CcSEcCtD
Telaprevir—Malnutrition—Vandetanib—thyroid cancer	0.00196	0.0105	CcSEcCtD
Telaprevir—Dysgeusia—Vandetanib—thyroid cancer	0.00192	0.0103	CcSEcCtD
Telaprevir—Anorectal discomfort—Doxorubicin—thyroid cancer	0.00189	0.0101	CcSEcCtD
Telaprevir—Oral candidiasis—Epirubicin—thyroid cancer	0.00176	0.00941	CcSEcCtD
Telaprevir—Loss of consciousness—Vandetanib—thyroid cancer	0.00172	0.00921	CcSEcCtD
Telaprevir—Infestation NOS—Sorafenib—thyroid cancer	0.00169	0.00904	CcSEcCtD
Telaprevir—Infestation—Sorafenib—thyroid cancer	0.00169	0.00904	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00168	0.00897	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00166	0.00886	CcSEcCtD
Telaprevir—Oral candidiasis—Doxorubicin—thyroid cancer	0.00163	0.0087	CcSEcCtD
Telaprevir—Hepatobiliary disease—Sorafenib—thyroid cancer	0.0016	0.00855	CcSEcCtD
Telaprevir—Infection—Vandetanib—thyroid cancer	0.00159	0.00849	CcSEcCtD
Telaprevir—Nervous system disorder—Vandetanib—thyroid cancer	0.00157	0.00839	CcSEcCtD
Telaprevir—Thrombocytopenia—Vandetanib—thyroid cancer	0.00157	0.00837	CcSEcCtD
Telaprevir—Skin disorder—Vandetanib—thyroid cancer	0.00156	0.00831	CcSEcCtD
Telaprevir—Urinary tract disorder—Sorafenib—thyroid cancer	0.0015	0.00802	CcSEcCtD
Telaprevir—Urethral disorder—Sorafenib—thyroid cancer	0.00149	0.00796	CcSEcCtD
Telaprevir—Erythema multiforme—Sorafenib—thyroid cancer	0.00144	0.00768	CcSEcCtD
Telaprevir—ORM1—lymph node—thyroid cancer	0.00143	0.0194	CbGeAlD
Telaprevir—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00138	0.00738	CcSEcCtD
Telaprevir—Fatigue—Vandetanib—thyroid cancer	0.00138	0.00737	CcSEcCtD
Telaprevir—Malnutrition—Sorafenib—thyroid cancer	0.00132	0.00707	CcSEcCtD
Telaprevir—Dysgeusia—Sorafenib—thyroid cancer	0.0013	0.00692	CcSEcCtD
Telaprevir—ALB—lymph node—thyroid cancer	0.00125	0.017	CbGeAlD
Telaprevir—Rectal haemorrhage—Epirubicin—thyroid cancer	0.00124	0.00661	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00123	0.00657	CcSEcCtD
Telaprevir—Anaemia—Sorafenib—thyroid cancer	0.00122	0.00653	CcSEcCtD
Telaprevir—Hyperuricaemia—Epirubicin—thyroid cancer	0.00121	0.00644	CcSEcCtD
Telaprevir—Syncope—Sorafenib—thyroid cancer	0.00119	0.00634	CcSEcCtD
Telaprevir—Loss of consciousness—Sorafenib—thyroid cancer	0.00116	0.00621	CcSEcCtD
Telaprevir—Asthenia—Vandetanib—thyroid cancer	0.00115	0.00613	CcSEcCtD
Telaprevir—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.00115	0.00612	CcSEcCtD
Telaprevir—Blood uric acid increased—Epirubicin—thyroid cancer	0.00114	0.00608	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00114	0.00608	CcSEcCtD
Telaprevir—Pruritus—Vandetanib—thyroid cancer	0.00113	0.00605	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00112	0.00598	CcSEcCtD
Telaprevir—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00112	0.00596	CcSEcCtD
Telaprevir—Diarrhoea—Vandetanib—thyroid cancer	0.0011	0.00585	CcSEcCtD
Telaprevir—Infection—Sorafenib—thyroid cancer	0.00107	0.00573	CcSEcCtD
Telaprevir—Candida infection—Epirubicin—thyroid cancer	0.00107	0.0057	CcSEcCtD
Telaprevir—Shock—Sorafenib—thyroid cancer	0.00106	0.00567	CcSEcCtD
Telaprevir—Nervous system disorder—Sorafenib—thyroid cancer	0.00106	0.00566	CcSEcCtD
Telaprevir—Dizziness—Vandetanib—thyroid cancer	0.00106	0.00565	CcSEcCtD
Telaprevir—Thrombocytopenia—Sorafenib—thyroid cancer	0.00106	0.00565	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00105	0.00563	CcSEcCtD
Telaprevir—Skin disorder—Sorafenib—thyroid cancer	0.00105	0.0056	CcSEcCtD
Telaprevir—Vomiting—Vandetanib—thyroid cancer	0.00102	0.00544	CcSEcCtD
Telaprevir—Rash—Vandetanib—thyroid cancer	0.00101	0.00539	CcSEcCtD
Telaprevir—Dermatitis—Vandetanib—thyroid cancer	0.00101	0.00539	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—thyroid cancer	0.000989	0.00528	CcSEcCtD
Telaprevir—Nausea—Vandetanib—thyroid cancer	0.000951	0.00508	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000933	0.00498	CcSEcCtD
Telaprevir—Fatigue—Sorafenib—thyroid cancer	0.000932	0.00497	CcSEcCtD
Telaprevir—Eczema—Epirubicin—thyroid cancer	0.000904	0.00483	CcSEcCtD
Telaprevir—Renal failure acute—Epirubicin—thyroid cancer	0.00088	0.0047	CcSEcCtD
Telaprevir—ABCB1—trachea—thyroid cancer	0.000858	0.0116	CbGeAlD
Telaprevir—Urticaria—Sorafenib—thyroid cancer	0.000858	0.00458	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—thyroid cancer	0.000836	0.00447	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—thyroid cancer	0.000814	0.00435	CcSEcCtD
Telaprevir—Asthenia—Sorafenib—thyroid cancer	0.000775	0.00414	CcSEcCtD
Telaprevir—Pruritus—Sorafenib—thyroid cancer	0.000764	0.00408	CcSEcCtD
Telaprevir—Blood creatinine increased—Epirubicin—thyroid cancer	0.000761	0.00406	CcSEcCtD
Telaprevir—Hypokalaemia—Epirubicin—thyroid cancer	0.000739	0.00395	CcSEcCtD
Telaprevir—Diarrhoea—Sorafenib—thyroid cancer	0.000739	0.00395	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000732	0.00391	CcSEcCtD
Telaprevir—Dizziness—Sorafenib—thyroid cancer	0.000714	0.00381	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000704	0.00376	CcSEcCtD
Telaprevir—Eosinophilia—Epirubicin—thyroid cancer	0.000695	0.00371	CcSEcCtD
Telaprevir—Vomiting—Sorafenib—thyroid cancer	0.000687	0.00367	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—thyroid cancer	0.000684	0.00365	CcSEcCtD
Telaprevir—Rash—Sorafenib—thyroid cancer	0.000681	0.00364	CcSEcCtD
Telaprevir—Dermatitis—Sorafenib—thyroid cancer	0.000681	0.00363	CcSEcCtD
Telaprevir—ABCB1—thyroid gland—thyroid cancer	0.000679	0.0092	CbGeAlD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000677	0.00361	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—thyroid cancer	0.000643	0.00343	CcSEcCtD
Telaprevir—Nausea—Sorafenib—thyroid cancer	0.000642	0.00343	CcSEcCtD
Telaprevir—Infestation NOS—Epirubicin—thyroid cancer	0.000626	0.00334	CcSEcCtD
Telaprevir—Infestation—Epirubicin—thyroid cancer	0.000626	0.00334	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000621	0.00331	CcSEcCtD
Telaprevir—ABCB1—head—thyroid cancer	0.000602	0.00817	CbGeAlD
Telaprevir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000592	0.00316	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—thyroid cancer	0.000579	0.00309	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—thyroid cancer	0.000579	0.00309	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000574	0.00307	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—thyroid cancer	0.000555	0.00296	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—thyroid cancer	0.000554	0.00296	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—thyroid cancer	0.000551	0.00294	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000548	0.00292	CcSEcCtD
Telaprevir—Erythema multiforme—Epirubicin—thyroid cancer	0.000531	0.00284	CcSEcCtD
Telaprevir—Eye disorder—Epirubicin—thyroid cancer	0.000525	0.0028	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000514	0.00274	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—thyroid cancer	0.000512	0.00273	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—thyroid cancer	0.00051	0.00272	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—thyroid cancer	0.000492	0.00262	CcSEcCtD
Telaprevir—Malnutrition—Epirubicin—thyroid cancer	0.000489	0.00261	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—thyroid cancer	0.000486	0.00259	CcSEcCtD
Telaprevir—Dysgeusia—Epirubicin—thyroid cancer	0.000479	0.00256	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—thyroid cancer	0.000453	0.00242	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—thyroid cancer	0.000452	0.00241	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—thyroid cancer	0.000443	0.00237	CcSEcCtD
Telaprevir—Syncope—Epirubicin—thyroid cancer	0.000439	0.00234	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—thyroid cancer	0.00043	0.0023	CcSEcCtD
Telaprevir—ABCB1—lymph node—thyroid cancer	0.000422	0.00572	CbGeAlD
Telaprevir—Anaemia—Doxorubicin—thyroid cancer	0.000418	0.00223	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000414	0.00221	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—thyroid cancer	0.000406	0.00217	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—thyroid cancer	0.000398	0.00212	CcSEcCtD
Telaprevir—Infection—Epirubicin—thyroid cancer	0.000397	0.00212	CcSEcCtD
Telaprevir—Shock—Epirubicin—thyroid cancer	0.000393	0.0021	CcSEcCtD
Telaprevir—Nervous system disorder—Epirubicin—thyroid cancer	0.000392	0.00209	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—thyroid cancer	0.000391	0.00209	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—thyroid cancer	0.000388	0.00207	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000383	0.00204	CcSEcCtD
Telaprevir—Infection—Doxorubicin—thyroid cancer	0.000367	0.00196	CcSEcCtD
Telaprevir—Shock—Doxorubicin—thyroid cancer	0.000363	0.00194	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—thyroid cancer	0.000362	0.00193	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000362	0.00193	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—thyroid cancer	0.000359	0.00192	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000345	0.00184	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—thyroid cancer	0.000344	0.00184	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000319	0.0017	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—thyroid cancer	0.000319	0.0017	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—thyroid cancer	0.000317	0.00169	CcSEcCtD
Telaprevir—Urticaria—Doxorubicin—thyroid cancer	0.000294	0.00157	CcSEcCtD
Telaprevir—Asthenia—Epirubicin—thyroid cancer	0.000286	0.00153	CcSEcCtD
Telaprevir—Pruritus—Epirubicin—thyroid cancer	0.000283	0.00151	CcSEcCtD
Telaprevir—Diarrhoea—Epirubicin—thyroid cancer	0.000273	0.00146	CcSEcCtD
Telaprevir—Asthenia—Doxorubicin—thyroid cancer	0.000265	0.00142	CcSEcCtD
Telaprevir—Dizziness—Epirubicin—thyroid cancer	0.000264	0.00141	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—thyroid cancer	0.000261	0.0014	CcSEcCtD
Telaprevir—Vomiting—Epirubicin—thyroid cancer	0.000254	0.00136	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—thyroid cancer	0.000253	0.00135	CcSEcCtD
Telaprevir—Rash—Epirubicin—thyroid cancer	0.000252	0.00134	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—thyroid cancer	0.000252	0.00134	CcSEcCtD
Telaprevir—Dizziness—Doxorubicin—thyroid cancer	0.000244	0.0013	CcSEcCtD
Telaprevir—Nausea—Epirubicin—thyroid cancer	0.000237	0.00127	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—thyroid cancer	0.000235	0.00125	CcSEcCtD
Telaprevir—Rash—Doxorubicin—thyroid cancer	0.000233	0.00124	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—thyroid cancer	0.000233	0.00124	CcSEcCtD
Telaprevir—Nausea—Doxorubicin—thyroid cancer	0.000219	0.00117	CcSEcCtD
